MicroRNA expression profiling and functional annotation analysis of their targets in patients with type 1 diabetes mellitus

Gene

Volumn 539, Issue 2, 2014, Pages 213-223

  Takahashi, Paula ^a   Xavier, Danilo J ^a   Evangelista, Adriane F ^a,b   Manoel Caetano, Fernanda S ^a   Macedo, Claudia ^a   Collares, Cristhianna V A ^a   Foss Freitas, Maria C ^a   Foss, Milton C ^a   Rassi, Diane M ^a   Donadi, Eduardo A ^a   Passos, Geraldo A ^a   Sakamoto Hojo, Elza T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b BARRETOS CANCER HOSPITAL   (Brazil)

Author keywords

Expression profile; Functional annotation analysis; Microarray; MicroRNA; T1DM candidate genes; Type 1 diabetes mellitus

Indexed keywords

MICRORNA; SMALL UNTRANSLATED RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DOWN REGULATION; FEMALE; FUNCTIONAL ANNOTATION ANALYSIS; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE TARGETING; GENETIC DATABASE; GENOME; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; MALE; MICROARRAY ANALYSIS; MOLECULAR GENETICS; PANCREAS ISLET BETA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RNA EXTRACTION; RNA HYBRIDIZATION; RNA PROCESSING; UPREGULATION; YOUNG ADULT;

EXPRESSION PROFILE; FUNCTIONAL ANNOTATION ANALYSIS; MICROARRAY; MICRORNA; T1DM CANDIDATE GENES; TYPE 1 DIABETES MELLITUS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; YOUNG ADULT;

EID: 84896715542     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.01.075     Document Type: Article

References (75)

1. ADA (American Diabetes Association) Diagnosis and classification of diabetes mellitus. Diabetes Care 2013, 36(Suppl. 1):S67-S74.
2. Antonelli A., et al. Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study. Diabet. Med. 2008, 25:1349-1353.
3. Argyropoulos C., et al. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PLoS One 2013, 8:e54662.
4. Balasubramanyam M., et al. Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes. Mol. Cell. Biochem. 2011, 351:197-205.
5. Barrett J.C., et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 2009, 41:703-707.
6. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
7. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
8. Bell G.I., Horita S., Karam J.H. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 1984, 33:176-183.
9. Bengtsson H. Aroma - an R object-oriented microarray analysis environment 2004, Centre for Mathematical Sciences, Lund University, (Preprint 2004:18, http://www.bioconductor.org/packages/release/bioc/html/aroma.light.html. Access March 10, 2013).
10. Bostjancic E., Zidar N., Stajer D., Glavac D. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 2010, 115:163-169.
11. Bottini N., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 2004, 36:337-338.
12. Burren O.S., Adlem E.C., Achuthan P., Christensen M., Coulson R.M., Todd J.A. T1DBase: update 2011, organization and presentation of large-scale data sets for type 1 diabetes research. Nucleic Acids Res. 2011, 39:D997-D1001.
13. Collares C.V., et al. Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients. BMC Res. Notes 2013, 6:491.
14. Danowski N., Manthey I., Jakob H.G., Siffert W., Peters J., Frey U.H. Decreased expression of miR-133a but not of miR-1 is associated with signs of heart failure in patients undergoing coronary bypass surgery. Cardiology 2013, 125:125-130.
15. Dong Y., et al. Tumor suppressor functions of miR-133a in colorectal cancer. Mol. Cancer Res. 2013, 11:1051-1060.
16. Dweep H., Sticht C., Pandey P., Gretz N. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J. Biomed. Inform. 2011, 44:839-847.
17. Eizirik D.L., et al. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet. 2012, 8:e1002552.
18. Enhanced Heat Map (heatmap.2) (Access April 10, 2013). http://hosho.ees.hokudai.ac.jp/~kubo/Rdoc/library/gplots/html/heatmap.2.html.
19. Glawe J.D., et al. SDF-1-CXCR4 differentially regulates autoimmune diabetogenic T cell adhesion through ROBO1-SLIT2 interactions in mice. Diabetologia 2013, 56:2222-2230.
20. Goodarzi M.T., Navidi A.A., Rezaei M., Babahmadi-Rezaei H. Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes. J. Clin. Lab. Anal. 2010, 24:72-76.
21. Grey F., et al. A viral microRNA down-regulates multiple cell cycle genes through mRNA 5'UTRs. PLoS Pathog. 2010, 6:e1000967.
22. Griffiths-Jones S. The microRNA registry. Nucleic Acids Res. 2004, 32:D109-D111.
23. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., Enright A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006, 34:D140-D144.
24. Griffiths-Jones S., Saini H.K., van Dongen S., Enright A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008, 36:D154-D158.
25. Hafner M., et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010, 141:129-141.
26. Hanifi-Moghaddam P., et al. Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus. Diabet. Med. 2006, 23:156-163.
27. Hata I., Kaji M., Hirano S., Shigematsu Y., Tsukahara H., Mayumi M. Urinary oxidative stress markers in young patients with type 1 diabetes. Pediatr. Int. 2006, 48:58-61.
28. Helwak A., Kudla G., Dudnakova T., Tollervey D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 2013, 153:654-665.
29. Hezova R., et al. microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cell. Immunol. 2010, 260:70-74.
30. Hierarchical Clustering (hclust) (Access April 10, 2013). http://stat.ethz.ch/R-manual/R-devel/library/stats/html/hclust.html.
31. Hong F., Breitling R., McEntee C.W., Wittner B.S., Nemhauser J.L., Chory J. RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 2006, 22:2825-2827.
32. Huang D.W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37:1-13.
33. Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
34. IDF (International Diabetes Federation) The global burden, IDF diabetes Atlas 5th edition (Access June 25, 2013). http://www.idf.org/diabetesatlas/5e/the-global-burden.
35. Jamieson N.B., et al. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin. Cancer Res. 2012, 18:534-545.
36. Karolina D.S., et al. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One 2011, 6:e22839.
37. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39:D152-D157.
38. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610.
39. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
40. Li L., et al. Suppression of the PI3K-Akt pathway is involved in the decreased adhesion and migration of bone marrow-derived mesenchymal stem cells from non-obese diabetic mice. Cell Biol. Int. 2011, 35:961-966.
41. Liew C.C., Ma J., Tang H.C., Zheng R., Dempsey A.A. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J. Lab. Clin. Med. 2006, 147:126-132.
42. Lim L.P., et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773.
43. Lin L., Lin Y., Jin Y., Zheng C. Microarray analysis of microRNA expression in liver cancer tissues and normal control. Gene 2013, 523:158-160.
44. Liu R., et al. Differential microRNA expression in peripheral blood mononuclear cells from Graves' disease patients. J. Clin. Endocrinol. Metab. 2012, 97:E968-E972.
45. Lowe C.E., et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat. Genet. 2007, 39:1074-1082.
46. Maechler M., Rousseeuw P., Struyf A., Hubert M., Hornik K. Cluster: cluster analysis basics and extensions. R package version 1.14.4 (Access March 10, 2013). http://cran.r-project.org/package=cluster.
47. Mao Y., Mohan R., Zhang S., Tang X. MicroRNAs as pharmacological targets in diabetes. Pharmacol. Res. 2013, 75:37-47.
48. Martin J., et al. Differentially expressed miRNAs in retinoblastoma. Gene 2013, 512:294-299.
49. Minones-Moyano E., et al. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum. Mol. Genet. 2011, 20:3067-3078.
50. Nielsen L.B., et al. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp. Diabetes Res. 2012, 2012:896362.
51. Nistico L., et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet. 1996, 5:1075-1080.
52. Oldham M.C., et al. Functional organization of the transcriptome in human brain. Nat. Neurosci. 2008, 11:1271-1282.
53. Oliveros J.C. VENNY. An interactive tool for comparing lists with Venn Diagrams (Access November 20, 2013). http://bioinfogp.cnb.csic.es/tools/venny/index.html.
54. Pauley K.M., Satoh M., Chan A.L., Bubb M.R., Reeves W.H., Chan E.K. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res. Ther. 2008, 10:R101.
55. Qin B., Huang F., Liang Y., Yang Z., Zhong R. Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 2013, 28:543-550.
56. R Development Core Team R: a language and environment for statistical computing 2006, R Foundation for Statistical Computing, (http://www.r-project.org. Access April 10, 2013).
57. Reczko M., Maragkakis M., Alexiou P., Grosse I., Hatzigeorgiou A.G. Functional microRNA targets in protein coding sequences. Bioinformatics 2012, 28:771-776.
58. Ridolfi E., et al. Expression and genetic analysis of MicroRNAs involved in multiple sclerosis. Int. J. Mol. Sci. 2013, 14:4375-4384.
59. Salas-Perez F., Codner E., Valencia E., Pizarro C., Carrasco E., Perez-Bravo F. MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes. Immunobiology 2013, 218:733-737.
60. Sebastiani G., Grieco F.A., Spagnuolo I., Galleri L., Cataldo D., Dotta F. Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity. Diabetes Metab. Res. Rev. 2011, 27:862-866.
61. Sharp C.D., et al. Stromal cell-derived factor-1/CXCL12 stimulates chemorepulsion of NOD/LtJ T-cell adhesion to islet microvascular endothelium. Diabetes 2008, 57:102-112.
62. Shu X., Ji J., Li X., Sundquist J., Sundquist K., Hemminki K. Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabet. Med. 2010, 27:791-797.
63. Sing T., Sander O., Beerenwinkel N., Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics 2005, 21:3940-3941. (http://rocr.bioinf.mpi-sb.mpg.de/).
64. Souza K.L., Elsner M., Mathias P.C., Lenzen S., Tiedge M. Cytokines activate genes of the endocytotic pathway in insulin-producing RINm5F cells. Diabetologia 2004, 47:1292-1302.
65. Tan J.R., et al. Blood microRNAs in Low or No Risk Ischemic Stroke Patients. Int. J. Mol. Sci. 2013, 14:2072-2084.
66. Tsukahara H., et al. Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes. Pediatr. Res. 2003, 54:419-424.
67. van Belle T.L., Coppieters K.T., von Herrath M.G. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol. Rev. 2011, 91:79-118.
68. Vaz C., et al. Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood. BMC Genomics 2010, 11:288.
69. Wang M.Y., et al. Iatrogenic hyperinsulinemia in type 1 diabetes: its effect on atherogenic risk markers. J. Diabetes Complications 2013, 27:70-74.
70. Warnes G.R., et al. Various R programming tools for plotting data, version 2.11.0.1 (http://cran.r-project.org/web/packages/gplots/index.html. Access April 10, 2013).
71. Wideroff L., et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J. Natl. Cancer Inst. 1997, 89:1360-1365.
72. Wightman B., Ha I., Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75:855-862.
73. Wong H.K., et al. De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease. Hum. Mol. Genet. 2013, 22:3077-3092.
74. Zendehdel K., Nyren O., Ostenson C.G., Adami H.O., Ekbom A., Ye W. Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J. Natl. Cancer Inst. 2003, 95:1797-1800.
75. Zhang J., et al. Differential expression profiling and functional analysis of microRNAs through stages I-III papillary thyroid carcinoma. Int. J. Med. Sci. 2013, 10:585-592.